RNS System LGS Feasibility Study
Trial details
- Registry ID
- NCT05339126
- Drugs studied
- RNS System
TrialRedline tracks 1 clinical trial sponsored by NeuroPace: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| RNS System LGS Feasibility StudyNCT05339126 | RNS System | Active not recruiting | 2026-11-30Estimated |
Names as written in the registry records.
NCT05339126 · NeuroPace
Before: 31 May 2026. After: 30 Nov 2026.
NCT05339126 · NeuroPace
Before: Recruiting. After: Active not recruiting.